BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396
193 results:

  • 1. TGF-β1/smad3-driven GLI2 isoform expression contributes to aggressive phenotypes of hepatocellular carcinoma.
    Ding J; Yang YY; Li PT; Ma Y; Zhang L; Zhou Y; Jin C; Li HY; Zhu YF; Liu XP; Liu ZJ; Jia HL; Liu PG; Wu J
    Cancer Lett; 2024 Apr; 588():216768. PubMed ID: 38453045
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TGF-β1 induces PD-1 expression in macrophages through smad3/STAT3 cooperative signaling in chronic inflammation.
    Lei Z; Tang R; Wu Y; Mao C; Xue W; Shen J; Yu J; Wang X; Qi X; Wei C; Xu L; Zhu J; Li Y; Zhang X; Ye C; Chen X; Yang X; Zhou S; Su C
    JCI Insight; 2024 Mar; 9(7):. PubMed ID: 38441961
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TIF1γ and smad4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. POH1 induces smad3 deubiquitination and promotes lung cancer metastasis.
    Yuan Y; Li Y; Wu X; Bo J; Zhang L; Zhang J; Hu Y; Chen Y; Zeng Y; Wei X; Zhang H
    Cancer Lett; 2024 Feb; 582():216526. PubMed ID: 38061486
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An NFATc1/smad3/cJUN Complex Restricted to smad4-Deficient Pancreatic cancer Guides Rational Therapies.
    Hasselluhn MC; Schlösser D; Versemann L; Schmidt GE; Ulisse M; Oschwald J; Zhang Z; Hamdan F; Xiao H; Kopp W; Spitalieri J; Kellner C; Schneider C; Reutlinger K; Nagarajan S; Steuber B; Sastra SA; Palermo CF; Appelhans J; Bohnenberger H; Todorovic J; Kostyuchek I; Ströbel P; Bockelmann A; König A; Ammer-Herrmenau C; Schmidleitner L; Kaulfuß S; Wollnik B; Hahn SA; Neesse A; Singh SK; Bastians H; Reichert M; Sax U; Olive KP; Johnsen SA; Schneider G; Ellenrieder V; Hessmann E
    Gastroenterology; 2024 Feb; 166(2):298-312.e14. PubMed ID: 37913894
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
    Zamani F; Khalighfard S; Kalhori MR; Poorkhani A; Amiriani T; Hosseinzadeh P; Esmati E; Alemrajabi M; Nikoofar A; Safarnezhad Tameshkel F; Alizadeh AM
    Med Oncol; 2023 Sep; 40(10):302. PubMed ID: 37725175
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/smad3 pathway.
    Deng L; Bao W; Zhang B; Zhang S; Chen Z; Zhu X; He B; Wu L; Chen X; Deng T; Chen B; Yu Z; Wang Y; Chen G
    Cell Death Dis; 2023 Sep; 14(9):590. PubMed ID: 37669935
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
    Lu G; Wang X; Cheng M; Wang S; Ma K
    Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Activin A/ACVR2A axis inhibits epithelial-to-mesenchymal transition in colon cancer by activating smad2.
    Zhang H; Ruan Q; Chen C; Yu H; Guan S; Hu D; Yang C; Lin R; Zhuo C
    Mol Carcinog; 2023 Oct; 62(10):1585-1598. PubMed ID: 37378449
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Amelioratory effects of astragaloside IV on hepatocarcinogenesis via Nrf2-mediated psmad3C/3L transformation.
    Fang Gong Y; Hou S; Xu JC; Chen Y; Zhu LL; Xu YY; Chen YQ; Li MM; Li LL; Yang JJ; Yang Y
    Phytomedicine; 2023 Aug; 117():154903. PubMed ID: 37301185
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Tang K; Li X; Mo J; Chen Y; Huang C; Li T; Luo T; Zhong Z; Jiang Y; Yang D; Mo W
    Sci Rep; 2023 May; 13(1):7452. PubMed ID: 37156819
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fibronectin 1 derived from tumor-associated macrophages and fibroblasts promotes metastasis through the JUN pathway in hepatocellular carcinoma.
    Zhang L; Zhang C; Xing Z; Lou C; Fang J; Wang Z; Li M; He H; Bai H
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109420. PubMed ID: 36461607
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-β1/smads pathway.
    Zhang R; Wang M; Lu H; Wang J; Han X; Liu Z; Li L; Li M; Tian X; Chen S; Zhang G; Xiong Y; Li J
    Adv Clin Exp Med; 2023 Apr; 32(4):469-479. PubMed ID: 36413180
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A micropeptide JunBP regulated by TGF-β promotes hepatocellular carcinoma metastasis.
    Zhang H; Liao Z; Wang W; Liu Y; Zhu H; Liang H; Zhang B; Chen X
    Oncogene; 2023 Jan; 42(2):113-123. PubMed ID: 36380240
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Apoptotic and Anti-metastatic Effects of Atractylodes lancea (Thunb.) DC. in a Hamster Model of Cholangiocarcinoma.
    Sonsomnuek P; Tarasuk M; Plengsuriyakarn T; Boonprasert K; Na-Bangchang K
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):3093-3101. PubMed ID: 36172672
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review.
    Ganguly R; Gupta A; Pandey AK
    World J Gastroenterol; 2022 Jul; 28(26):3047-3062. PubMed ID: 36051349
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. TGF-β1/smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
    Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
    J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. RNA
    Tan B; Zhou K; Liu W; Prince E; Qing Y; Li Y; Han L; Qin X; Su R; Pokharel SP; Yang L; Zhao Z; Shen C; Li W; Chen Z; Zhang Z; Deng X; Small A; Wang K; Leung K; Chen CW; Shen B; Chen J
    Theranostics; 2022; 12(13):5727-5743. PubMed ID: 35966596
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the smad3-CDK4/CDK6-cyclin D1 and CXCR4/RhoA pathways.
    Zhao M; Wang Y; Zhang Y; Li X; Mi J; Wang Q; Geng Z; Zuo L; Song X; Ge S; Zhang Z; Tang M; Li H; Wang Z; Jiang C; Su F
    BMC Gastroenterol; 2022 Aug; 22(1):378. PubMed ID: 35941537
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/smad3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.